InvestorsHub Logo
Followers 0
Posts 421
Boards Moderated 0
Alias Born 04/17/2018

Re: None

Thursday, 05/17/2018 3:52:03 PM

Thursday, May 17, 2018 3:52:03 PM

Post# of 18666
$GTBP The depth and experience of the leadership team here is a very telling indicator of where GT Biopharma is heading. "Look at Where Deutsche Bank’s Shawn Cross, Pfizer’s Dr. Raymond Urbanski, Chase Pharmaceutical’s Dr. Kathleen Clarence-Smith, and Barker Davis Founder Geoffrey Davis are making their bets. Some of the biotech sector’s most affluent and influential individuals are making a move... to GT Biopharma Inc. (GTBP). This up-and-coming biotech company has a therapy pipeline that has attracted some of the industry’s most experienced leaders."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTBP News